Cita APA

Tutusaus, A., Stefanovic, M., Boix, L., Cucarull, B., Zamora, A., Blasco, L., . . . Morales, A. (2018). Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma. Oncotarget.

Citación estilo Chicago

Tutusaus, Anna, et al. "Antiapoptotic BCL-2 Proteins Determine Sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma." Oncotarget 2018.

Cita MLA

Tutusaus, Anna, et al. "Antiapoptotic BCL-2 Proteins Determine Sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma." Oncotarget 2018.